Is CBD Legal in Brazil?

CBD is legal in Brazil only through medical channels regulated by ANVISA. The framework rests on RDC 327/2019, which created the Cannabis Product category and a five-year Sanitary Authorization for manufacture, import, prescription, and dispensing through licensed pharmacies. Authorized products must contain predominantly CBD; products with more than 0.2% THC are restricted to terminally ill or treatment-refractory patients. There is no over-the-counter or wellness CBD market.

Patients who cannot access ANVISA-authorized products domestically may import CBD for personal use under RDC 660/2022. Patients or their legal representatives register through the gov.br portal, upload a valid medical prescription, and obtain an exceptional import authorization valid for up to two years. About 47% of Brazilian medical cannabis patients still rely on this personal-import route. Habeas corpus rulings have also allowed select patients to cultivate at home for medicinal use. Mevatyl (nabiximols) remains the only fully registered cannabis-based medicine, approved in January 2017 for multiple sclerosis spasticity.

This page is for informational purposes only and does not constitute legal advice. Verify current law with qualified counsel before making compliance decisions.